tradingkey.logo
tradingkey.logo

US FDA approves higher dose of Wegovy

ReutersMar 19, 2026 3:49 PM

- Novo Nordisk NOVOb.CO said on Thursday the U.S. Food and Drug Administration has approved a high dose of Wegovy to reduce excess body weight and maintain weight reduction long term.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI